January 5, 2021 – Integra LifeSciences Holdings Corporation (Princeton, NJ), announced it has completed its previously announced divestiture of its Extremity Orthopedics business to Smith+Nephew.
“With this divestiture, we will now be in an even stronger position to capitalize on our core products and technologies in neurosurgery and regenerative medicine, and provide greater value to our customers and shareholders,” said Peter Arduini, president and CEO, Integra LifeSciences. “We want to thank the orthopedics team for their contributions to Integra’s success and wish them all the best for their future.”
Terms of the transaction were not disclosed.